DexCom, Inc. (NASDAQ:DXCM) Q2 2024 Earnings Conference Call July 25, 2024 4:30 PM ET
Corporate Participants
Sean Christensen - Vice President of Finance, and Investor Relations
Kevin Sayer - Chairman, President, and Chief Executive Officer
Jereme Sylvain - Chief Financial Officer
Conference Call Participants
Robbie Marcus - JPMorgan
Larry Biegelsen - Wells Fargo
Jeff Johnson - Baird
Magaret Andrew - William Blair
Travis Steed - Bank of America
Matt Taylor - Jefferies
Danielle Antalffy - UBS
Joanne Wuensch - Citibank
Matthew O'Brien - Piper Sandler
Sam Eiber - BTIG
Mathew Blackman - Stifel
Jason Bedford - Raymond James
Steve Lichtman - Oppenheimer
Mike Polark - Wolfe Research
Shagun Singh - RBC Capital Markets
Bill Plovanic - Canaccord Genuity
Chris Pasquale - Nephron
Matt Miksic - Barclays
Operator
Welcome to the DexCom Second Quarter 2024 Earnings Release Conference Call. My name is Abby and I'll be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] As a reminder, the conference is being recorded.
I will now turn the call over to Sean Christensen. You may begin.
Sean Christensen
Thank you, Abby, and welcome to DexCom's second quarter 2024 earnings call. Our agenda begins with Kevin Sayer, DexCom's Chairman, President, and CEO, who will summarize our recent highlights and ongoing strategic initiatives, followed by a financial review and outlook from Jereme Sylvain, our Chief Financial Officer. Following our prepared remarks, we will open the call up for your questions.
At that time, we ask analysts to limit themselves to one question each so we can provide an opportunity for everyone participating today. Please note that there are also slides available related to our second Quarter 2024 performance on the DexCom Investor Relations website on the Events and Presentations page. With